首页 | 本学科首页   官方微博 | 高级检索  
检索        


Antiasthmatic action of dibenzylbutyrolactone lignans from fruits of Forsythia viridissima on asthmatic responses to ovalbumin challenge in conscious guinea‐pigs
Authors:Jin Hee Lee  Ji Yun Lee  Tae Doo Kim  Chang Jong Kim
Institution:Division of Pathophysiology, College of Pharmacy, Chung‐Ang University, Seoul 156‐756, Korea
Abstract:It was reported previously that dibenzylbutyrolactone lignans from Forsythia viridissima fruits, which are traditional medicines for the treatment of inflammatory diseases, have antiinflammatory effects. In this study, the effects on the immediate‐phase response (IAR) and late‐phase response (LAR) following aerosolized‐ovalbumin challenge in ovalbumin‐sensitized guinea‐pigs were evaluated by measuring the specific airway resistance (sRaw), recruitment of leukocytes and chemical mediators in the bronchoalveolar lavage fluids (BALF) as well as a histopathological survey. Arctiin and matairesinol at 12.5 mg/kg significantly (p < 0.05) decreased sRaw by 51.83% and 43.15% in IAR and by 47.41% and 35.43% in LAR, respectively, whereas arctigenin at 25 mg/kg was significantly active, compared with the controls. Furthermore, arctiin and arctigenin dose‐dependently inhibited histamine, and the activities of phospholipase A2 (PLA2) and eosinophil peroxidase (EPO) in BALF, respectively, whereas matairesinol inhibited EPO and PLA2 at 12.5 mg/kg and histamine at 50 mg/kg, in addition, they moderately improved the infiltration of eosinophils, compared with controls. Dexamethasone, cromolyn and salbutamol significantly inhibited sRaw in both IAR and LAR, and the recruitment of leukocytes and chemical mediators, whereas salbutamol did not alter chemical mediators, in BALF. These results indicate the three lignans have antiasthmatic effects which were less active than those of the reference drugs. Copyright © 2010 John Wiley & Sons, Ltd.
Keywords:dibenzylbutyrolactone lignans  sRaw  histamine  PLA2  EPO  antiasthmatic
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号